Q: Is UV-crosslinked RIP-seq the same as CLIP-seq?

A: No. Both use UV irradiation, but UV-crosslinked RIP-seq omits the gel isolation and membrane-transfer steps used in canonical CLIP workflows. It is designed for localized enrichment analysis, not guaranteed nucleotide-resolution contact mapping.

Q: Does UV crosslinking prove every recovered RNA directly contacts the target RBP?

A: No. UV preferentially stabilizes close contacts, but immunoprecipitation can retain parts of an RNP complex, and peak width depends on fragmentation and analysis. Directness should be tested with orthogonal assays when it is central to the conclusion.

Q: Why are both input and IgG controls recommended?

A: Input captures transcript abundance and fragmentation background, while IgG helps identify nonspecific bead- or antibody-associated RNA. Using both makes enrichment interpretation more defensible.

Q: What antibody evidence is most useful?

A: RIP or IP validation is preferred, together with lot information, a clear band at the expected molecular weight, and evidence of target enrichment. ChIP-only validation is not sufficient for an RNA-binding workflow.

Q: Can the service analyze alternative splicing?

A: Yes, especially when matched RNA-seq is available. Binding regions near introns or splice junctions can be integrated with regulated splicing events to prioritize candidate RBP-dependent mechanisms.

Q: Can I submit tissue instead of cultured cells?

A: Selected tissues are feasible, but UV penetration, tissue dissociation, target abundance, endogenous nuclease activity, and sample preservation must be reviewed before collection.

UV-Crosslinked RIP-seq Service for RBP–RNA Binding Analysis

Go beyond transcript-level RIP-seq with stabilized RBP–RNA complexes and more localized binding-region analysis—without the full complexity of CLIP-seq.

Native RIP-seq can return a long list of associated transcripts while leaving the RBP-bound region unclear, and unstable contacts may be lost after lysis. This can make motif discovery and selection of mechanistic validation targets difficult.

UV-crosslinked RIP-seq combines in-cell interaction stabilization, controlled RNA fragmentation, immunoprecipitation, and sequencing. CD Genomics supports experimental design, library preparation, regional enrichment analysis, motif discovery, and integration with transcriptomic data.

Stabilize protein–RNA contacts before cell lysis
Profile enriched RNA regions rather than full transcripts alone
Connect RBP occupancy with motifs, splicing, stability, and expression
Use input and IgG controls to strengthen enrichment interpretation

Discuss Your RBP Project

Conceptual view of UV-stabilized RNA-binding protein complexes and localized enriched RNA regions

Introduction

What Is UV-Crosslinked RIP-seq?

UV-crosslinked RIP-seq profiles RNAs associated with a selected RNA-binding protein after ultraviolet irradiation stabilizes close protein–RNA contacts in intact cells. Controlled fragmentation and immunoprecipitation recover RBP-associated RNA regions for sequencing, while comparisons with input and IgG controls identify reproducible enrichment, motifs, and target transcripts.

This method occupies a practical middle ground between conventional RIP-seq and multi-step CLIP workflows. Fragmentation can provide more localized binding-region information than native RIP-seq, while the omission of gel isolation and membrane transfer reduces workflow complexity. However, UV-crosslinked RIP-seq is not equivalent to nucleotide-resolution CLIP: co-purified complexes and fragment length can broaden peaks, and crosslinking efficiency varies with the RBP, RNA sequence, and contact chemistry.

Best suited for

Transcriptome-wide target discovery for an RBP with a validated antibody
Regional binding analysis across coding, intronic, and untranslated regions
RBP motif discovery and target-network construction
Integration with expression or alternative-splicing changes

Consider another method when

Exact crosslink nucleotides are required for the central hypothesis
The target does not UV-crosslink efficiently or cannot be immunoprecipitated
The research question concerns RNA modification rather than an RBP
Only a small set of predefined transcripts requires validation

Workflow

UV-Crosslinked RIP-seq Workflow

The workflow is optimized around the biological material, RBP abundance, antibody performance, and the scale at which binding needs to be interpreted. Project-specific reagent concentrations and processing conditions are finalized during technical review.

1. Feasibility Review

We assess the research question, target localization, sample condition, antibody validation, controls, and replicate plan so recovery risks can be addressed before sample collection.

2. UV Stabilization

Protein–RNA contacts are stabilized in intact cells or appropriately prepared material before lysis, reducing post-lysis reassociation.

3. Controlled RNA Fragmentation

RNA is partially fragmented to support regional enrichment analysis while retaining sufficient sequence for alignment.

4. RBP Immunoprecipitation

The target complex is enriched with the selected antibody alongside input and IgG controls, helping separate RBP-associated signal from abundance and nonspecific background.

5. RNA Recovery and Sequencing

RBP-associated fragments are recovered, converted into sequencing libraries, quality controlled, and sequenced so comparable evidence is available across IP and control libraries.

6. Binding-Region Analysis

Enriched regions are called, annotated, compared across groups, and integrated with motifs or functional transcriptomic data to prioritize testable RBP targets.

Project-specific workflow from interaction stabilization through region-level RBP–RNA interpretation

Sample Requirements

Sample Requirements and Study Controls

The following quantities are initial planning baselines. Acceptance depends on target abundance, immunoprecipitation efficiency, species, tissue composition, and whether the project uses an endogenous or tagged protein.

Material	Planning baseline	Key considerations
Cultured cells	Typically at least 1 × 10^8 cells per sample	Use healthy cells with consistent confluence, treatment, collection, and handling.
Animal tissue	Typically at least 500 mg per sample	Fresh or rapidly frozen material is preferred; avoid repeated freeze–thaw cycles.
Plant tissue	Typically at least 5 g per sample	Species, tissue structure, endogenous nuclease activity, and metabolites require review.
Antibody	RIP- or IP-validated antibody; 10–15 µg per IP is a planning baseline	Provide lot-specific validation, expected RBP size, and known positive RNA when available.
Controls and replicates	Matched input and IgG controls; at least two biological replicates	Three biological replicates are preferred for differential binding studies.

If only several candidate RNAs need confirmation, RIP-qPCR may be more efficient. If the target is poorly recovered by the selected antibody, a validated epitope-tag strategy can be considered where biologically appropriate.

Evaluate Your RBP and Sample Design

Bioinformatics

Bioinformatics for RBP-Bound RNA Regions

Analysis is structured to distinguish general transcript abundance from immunoprecipitation enrichment. Input and IgG evidence, replicate concordance, region-level signal, and transcript annotations are evaluated together.

Sequencing configuration

Item	Project configuration	Why it matters
Sequencing platform	Illumina short-read sequencing system	High-throughput sequencing supports reproducible comparison of immunoprecipitated, input, and IgG libraries.
Read configuration	Paired-end sequencing; read length finalized after RNA-fragment and library review	Paired observations improve placement of fragmented RBP-associated RNA and support regional enrichment analysis.
Recommended data amount	Customized to transcriptome complexity, target abundance, enrichment, controls, and replicate design	Project-specific depth balances target discovery with the evidence needed for between-condition comparison.
Primary analytical objective	IP-versus-input and IP-versus-IgG enrichment with reproducible binding-region detection	This separates abundance-driven signal from RBP-associated enrichment and produces a prioritized set of interpretable RNA regions.

The exact instrument model, read length, and sequencing depth are confirmed during project design after the RBP, RNA-fragment profile, reference annotation, controls, and study objective have been reviewed.

Standard analysis

Raw-read quality control and adapter processing to remove avoidable technical noise before enrichment analysis
Reference genome or transcriptome alignment to place recovered fragments in transcript context
Library complexity and duplicate-pattern review to identify libraries with limited independent signal
IP-versus-input and IP-versus-IgG enrichment analysis to separate RBP association from abundance and nonspecific background
Reproducible binding-region detection across replicates to prioritize stable candidates
Annotation to coding regions, introns, and untranslated regions to connect occupancy with RNA processing or regulation
Metagene profiles, motifs, genome-browser tracks, and target lists for interpretation and downstream validation planning

Optional integrated analysis

Differential RBP binding across conditions to identify regulated occupancy
Binding–expression integration with RNA-seq to connect occupancy with transcript response
Binding–splicing integration to prioritize RBP-associated alternative-splicing events
Functional enrichment and RBP-centered regulatory networks to organize targets into biological themes
Comparison with RNA-modification enrichment profiles to explore modification-sensitive binding
Prioritization of regions for RIP-qPCR or reporter validation to focus experimental follow-up

Representative result types are shown conceptually; project figures depend on the RBP, controls, and study design

Deliverables

UV-Crosslinked RIP-seq Deliverables

Sequence and Alignment Data

Quality-controlled FASTQ files, alignment files, normalized tracks, and summary metrics support transparent downstream review.

Binding-Region Results

Enriched regions, transcript annotations, motifs, target-gene tables, metagene distributions, and replicate comparisons.

Biological Interpretation

Functional enrichment, optional differential and integrated analyses, figures, methods documentation, and a final project report.

Applications

Research Applications

RNA Stability and Translation

Map RBP-associated regions on mRNAs and test whether condition-specific occupancy aligns with changes in transcript abundance, decay, or translational regulation.

Alternative Splicing and RNA Processing

Identify binding near introns and exon boundaries, then integrate occupancy with differential splicing to prioritize candidate regulatory events.

lncRNA–Protein Regulatory Networks

Profile lncRNAs associated with metabolic enzymes, chromatin proteins, or canonical RBPs and build networks for focused biochemical validation.

RNA Modification Readers

Examine how m6A readers or other modification-sensitive RBPs occupy candidate transcripts and integrate their binding with RNA-modification data.

Cancer and Cell-State Regulation

Study how RBP binding changes across oncogenic perturbations, drug response, proliferation, differentiation, or stress without treating association as proof of causality.

Inflammation and Immune Signaling

Characterize stimulus-dependent RBP targets in macrophages, lymphoid models, or other immune systems and connect binding with pathway-level expression changes.

Stress and Environmental Response

Compare RBP occupancy under hypoxia, nutrient stress, oxidative stress, heat, or other controlled conditions across animal, plant, or microbial models.

Host–Pathogen Interaction

Profile host or pathogen RBP-associated transcripts to prioritize RNA-regulatory nodes involved in infection and cellular response.

Case Study

Case Study: Connecting IGF2BP2 Binding with NOTCH1 Regulation in T-ALL

IGF2BP2 Binding and NOTCH1 Regulation

Source: Feng P, Chen D, Wang X, et al. Inhibition of the m6A reader IGF2BP2 as a strategy against T-cell acute lymphoblastic leukemia. Leukemia. 2022;36:2180–2188.

Background: IGF2BP2 is an RNA-binding m6A reader implicated in cancer, but its transcriptome-wide targets and relationship to T-cell acute lymphoblastic leukemia biology required clarification.

Methods: The researchers applied UV-crosslinked improved RIP-seq in Jurkat cells and integrated two replicate binding profiles with RNA-seq, m6A enrichment data, RIP-qPCR, RNA pull-down assays, and perturbation experiments.

Results: IGF2BP2-associated reads were concentrated in protein-coding RNAs and enriched in coding regions. Integrated analysis prioritized a set of overlapping bound and regulated genes, including NOTCH1. Orthogonal assays supported IGF2BP2 association with NOTCH1 RNA and linked the interaction to m6A-dependent transcript stability.

Conclusion: The study demonstrates how UV-stabilized RBP occupancy can be combined with transcriptomic and modification data to move from a target list toward a testable regulatory mechanism. Association peaks alone do not establish direct binding or causality and should be followed by orthogonal validation.

Original conceptual redraw of the published biological conclusion; not literature data or a reproduced paper figure

Comparison

RIP-seq vs. UV-Crosslinked RIP-seq vs. CLIP-based Methods

Method	Interaction capture	Typical output	Best fit
Native RIP-seq	Noncovalent complexes enriched after lysis	Associated transcripts and broad enrichment	Stable RNP complexes and transcript-level target discovery
UV-crosslinked RIP-seq	UV-stabilized contacts plus controlled RNA fragmentation	Regional enrichment, motifs, and target transcripts	Localized RBP association with a streamlined workflow
eCLIP-seq	UV crosslinking with stringent size-based purification	Higher-resolution crosslink-informed binding sites	Direct-contact mapping when extra purification and complexity are justified
PAR-CLIP-seq	Photoactivatable nucleoside labeling and long-wave UV crosslinking	Mutation-supported interaction sites	Compatible cultured-cell systems that can incorporate photoactivatable nucleosides

Best for: UV-crosslinked RIP-seq is suited to regional RBP enrichment, motif discovery, and integrated target prioritization. Consider another method: use eCLIP when stringent direct-contact mapping is central, native RIP-seq for transcript-level association screening, or PAR-CLIP in compatible labeled-cell systems when mutation-supported sites are required.

Method selection should follow the required interaction resolution, sample system, and validation strategy

FAQ

Frequently Asked Questions

Project Review

Build an RBP Study with the Right Resolution

Share the RBP, species, sample type, target localization, antibody evidence, experimental groups, available material, and whether the primary endpoint is target discovery, binding localization, differential occupancy, or integration with expression and splicing.

Request a Project Review

References

Wang X, Ji Y, Feng P, et al. The m6A reader IGF2BP2 regulates macrophage phenotypic activation and inflammatory diseases by stabilizing TSC1 and PPARγ. Advanced Science. 2021;8(13):2100209. DOI: 10.1002/advs.202100209
Feng P, Chen D, Wang X, et al. Inhibition of the m6A reader IGF2BP2 as a strategy against T-cell acute lymphoblastic leukemia. Leukemia. 2022;36(9):2180–2188. DOI: 10.1038/s41375-022-01651-9
Ren T, Wang S, Zhang B, et al. LTA4H extensively associates with mRNAs and lncRNAs indicative of its novel regulatory targets. PeerJ. 2023;11:e14875. DOI: 10.7717/peerj.14875
Wang N, Qiao H, Hao J, et al. RNA-binding protein ENO1 promotes the tumor progression of gastric cancer by binding to and regulating gastric cancer-related genes. Journal of Gastrointestinal Oncology. 2023;14(2):585–598. DOI: 10.21037/jgo-23-151
Esteban-Serna S, McCaughan H, Granneman S. Advantages and limitations of UV cross-linking analysis of protein–RNA interactomes in microbes. Molecular Microbiology. 2023;120(4):477–489. DOI: 10.1111/mmi.15073

For research use only. Not for use in diagnostic procedures.

! For research purposes only. Not intended for clinical diagnosis, treatment, or individual health assessments.